Credelio Chewable Tablets for Cats

Login to see prices

SKU: N/A Categories: , ,

Description

Details

  • The first tick and flea infestation prevention and treatment chewable tablet for cats & kittens 4.1 to 17.0 lbs., 8+ weeks of age
  • Fast-acting ingredients start killing adult fleas in just 6 hours
  • Small, tasty chewable tablet made with vanilla & yeast to appeal to cats
  • Works hard all month long
  • Easy to give; Credelio CAT was successfully given by over 99% of cat owners (Chappell K, Paarlberg T, Seewald W, et al. A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio® CAT) in eliminating fleas in client-owned cats in the USA. Parasite Vector. 2021;14:127.)

 

Credelio CAT is the first tick and flea chewable tablet that protects cats 4.1-17.0 lbs., 8 weeks or older, for 30 days.
Specifications
Generic Name lotilaner
Common Brand Name(s) Credelio
For Use With Cats
Administration Form Oral
Made In Switzerland
Repels or Prevents Fleas
Kills or Treats Fleas
Lifestage Adult
Breed Size All Breeds
Product Form Chewable Tablet
Strength 48 mg Lotilaner
Health Condition Fleas
Drug Type Parasiticide
Uses

CREDELIO CAT kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) for one month in cats and kittens 8 weeks of age and older, and weighing 2.0 pounds or greater. CREDELIO CAT is also indicated for the treatment and control of Ixodes scapularis (black-legged tick) infestations for one month in cats and kittens 6 months of age and older, and weighing 2.0 pounds or greater.

Possible Side Effects

In a well-controlled U.S. field study, which included 341 cats (228 cats treated with CREDELIO CAT and 113 cats treated with a topical active control), there were no serious adverse reactions.

Precautions

Lotilaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, incoordination, and seizures. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders. The safety of Credelio CAT has not been established in breeding, pregnant and lactating cats. The most frequently reported adverse reactions are weight loss, rapid breathing and vomiting. For complete safety information, please see Credelio CAT product label or ask your veterinarian.

Details